BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28703)

  • 21. [Comparative study of the pre and post-synaptic alpha blocking activity of thymoxamine and its metabolites in the rat vas deferens (author's transl)].
    Roquebert J; Demichel P; Malek A; Canellas J
    J Pharmacol; 1981; 12(1):15-25. PubMed ID: 6111626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of subchronic exposure of rats to lead or zinc on alpha-adrenoceptor-mediated contractile responses in isolated vas deferens.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D; Lasova L; Radomirov R
    Acta Physiol Pharmacol Bulg; 1993; 19(4):111-9. PubMed ID: 8203281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsiveness of the rat vas deferens to catecholamines and electrical stimulation during an infection with Trypanosoma brucei.
    Adeboye OO; Oriowo MA
    Afr J Med Med Sci; 1984; 13(3-4):135-8. PubMed ID: 6099973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dimethylphenylpiperazinium on the amine uptake process.
    Jayasundar S; Vohra MM
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):37-41. PubMed ID: 931465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the blocking effect of alpha-adrenoceptor antagonist drugs towards directly and indirectly acting agonists on the rat vas deferens.
    Lucchelli A; Santagostino-Barbone MG; D'Agostino G; Grana E
    Pharmacol Res Commun; 1983 Mar; 15(3):267-80. PubMed ID: 6134294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants.
    Güneş A; Ceylan A; Sarioglu Y; Stefek M; Bauer V; Karasu C;
    Fundam Clin Pharmacol; 2005 Feb; 19(1):73-9. PubMed ID: 15660962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of non-adrenergic transmission in the rat vas deferens.
    Ebong OO; Zar MA
    Neuropharmacology; 1989 Apr; 28(4):335-41. PubMed ID: 2546086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens.
    Celuch SM; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate limiting factors in sympathetic neurotransmitter secretion.
    Stjärne L
    Acta Physiol Scand; 1975 Feb; 93(2):220-7. PubMed ID: 167548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inhibition of post-ganglionic motor transmission in the mammalian vas deferens by D-lysergic acid diethylamide.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1973 Jun; 231(2):251-70. PubMed ID: 4352765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific alpha-adrenoceptor blocking effect of droperidol on isolated smooth muscles.
    van Nueten JM; Reneman RS; Janssen PA
    Eur J Pharmacol; 1977 Jul; 44(1):1-8. PubMed ID: 18356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potentiating effects of 4-aminopyridine on adrenergic transmission in the rabbit vas deferens.
    Johns A; Golko DS; Lauzon PA; Paton DM
    Eur J Pharmacol; 1976 Jul; 38(1):71-8. PubMed ID: 182508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholamine functions.
    Axelsson J
    Annu Rev Physiol; 1971; 33():1-30. PubMed ID: 4377646
    [No Abstract]   [Full Text] [Related]  

  • 35. Altered alpha-adrenergic responses of vas deferens to noradrenaline and tyramine from rats with short- and long-term alloxan diabetes.
    Oztürk Y; Yildizoğlu-Ari N; Altan VM
    Gen Pharmacol; 1994 Nov; 25(7):1519-24. PubMed ID: 7896069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.
    Finberg JP; Tenne M
    Br J Pharmacol; 1982 Sep; 77(1):13-21. PubMed ID: 6127132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of release and depletion of endogenous noradrenaline on the transmission of impulses in the mouse vas deferens.
    Marshall I; Nasmyth PA; Shepperson NB
    Br J Pharmacol; 1978 Sep; 64(1):145-51. PubMed ID: 212149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pancuronium bromide on the adrenergic reactivity of the isolated rat vas deferens.
    Quintana A
    Eur J Pharmacol; 1977 Dec; 46(3):275-7. PubMed ID: 590336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urodilatin attenuates sympathetic neurotransmission in the rabbit isolated vas deferens without activating guanylyl cyclase.
    Trachte GJ
    Life Sci; 2001 Nov; 69(24):2833-44. PubMed ID: 11720087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tentative transmission mechanism for the twitch elicited in guinea-pig vas deferens by field stimulation.
    von Euler US; Hedqvist P
    Med Hypotheses; 1975; 1(6):214-6. PubMed ID: 6863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.